Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study

American Journal of Kidney Diseases

Volumn 66, Issue 2, 2015, Pages 266-273

  Shah, Rachana ^a   Matthews, Gregory J ^b   Shah, Rhia Y ^c   McLaughlin, Catherine ^d   Chen, Jing ^e   Wolman, Melanie ^c   Master, Stephen R ^c   Chai, Boyang ^c   Xie, Dawei ^c   Rader, Daniel J ^c   Raj, Dominic S ^f   Mehta, Nehal N ^g   Budoff, Matthew ^h   Fischer, Michael J ^i,j   Go, Alan S ^k   Townsend, Raymond R ^l   He, Jiang ^e   Kusek, John W ^m   Feldman, Harold I ^c,l   Foulkes, Andrea S ^b   Reilly, Muredach P ^c   Appel, Lawrence J ⁿ   Lash, James P ⁿ   Ojo, Akinlolu ⁿ   Rahman, Mahboob ⁿ   more..

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e TULANE UNIVERSITY   (United States)

^f GEORGE WASHINGTON UNIVERSITY   (United States)

^g NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^h LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

ⁱ JESSE BROWN VA MEDICAL CENTER   (United States)

^j HINES VA HOSPITAL   (United States)

^k DIVISION OF RESEARCH   (United States)

^l UNIVERSITY OF PENNSYLVANIA   (United States)

^m NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

ⁿ NONE

more..

Author keywords

atherosclerosis; cardiovascular disease (CVD); chronic kidney disease (CKD); Chronic Renal Insufficiency Cohort; diabetes; fractalkine (CX3CL1); Index Words Cardiometabolic disease; metabolic syndrome

Indexed keywords

CREATININE; CYSTATIN C; FRACTALKINE; HEMOGLOBIN A1C; CX3CL1 PROTEIN, HUMAN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; INSULIN RESISTANCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; AGED; BLOOD; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; STATISTICAL MODEL;

AGED; CARDIOVASCULAR DISEASES; CHEMOKINE CX3CL1; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84937967994     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2015.01.021     Document Type: Article

References (33)

1. M.J. Sarnak, A.S. Levey, A.C. Schoolwerth, and et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation 108 17 2003 2154 2169
2. S. Apostolakis, and D. Spandidos Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway Acta Pharmacol Sinica 34 10 2013 1251 1256
3. R. Shah, C.C. Hinkle, J.F. Ferguson, and et al. Fractalkine is a novel human adipochemokine associated with type 2 diabetes Diabetes 60 5 2011 1512 1518
4. G.E. White, and D.R. Greaves Fractalkine: a survivor's guide: chemokines as antiapoptotic mediators Arterioscler Thromb Vasc Biol 32 3 2012 589 594
5. G.A. Chapman, K.E. Moores, J. Gohil, and et al. The role of fractalkine in the recruitment of monocytes to the endothelium Eur J Pharmacol 392 3 2000 189 195
6. A. Schlitt, G.H. Heine, S. Blankenberg, and et al. CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels Thromb Haemost 92 2 2004 419 424
7. D. Moatti, S. Faure, F. Fumeron, and et al. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease Blood 97 7 2001 1925 1928
8. E. Lavergne, J. Labreuche, M. Daoudi, and et al. Adverse associations between CX3CR1 polymorphisms and risk of cardiovascular or cerebrovascular disease Arterioscler Thromb Vasc Biol 25 4 2005 847 853
9. D. Sirois-Gagnon, A. Chamberland, S. Perron, D. Brisson, D. Gaudet, and C. Laprise Association of common polymorphisms in the fractalkine receptor (CX3CR1) with obesity Obesity 19 1 2011 222 227
10. M.J. Fischer, A.S. Go, C.M. Lora, and et al. CKD in Hispanics: baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic-CRIC Studies Am J Kidney Dis 58 2 2011 214 227
11. J.P. Lash, A.S. Go, L.J. Appel, and et al. Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function Clin J Am Soc Nephrol 4 8 2009 1302 1311
12. H.I. Feldman, L.J. Appel, G.M. Chertow, and et al. The Chronic Renal Insufficiency Cohort (CRIC) Study: design and methods J Am Soc Nephrol 14 7 suppl 2 2003 S148 S153
13. J.K. Damas, T. Waehre, A. Yndestad, and et al. Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects Circulation 106 1 2002 36 42
14. N.N. Mehta, M. Li, D. William, and et al. The novel atherosclerosis locus at 10q11 regulates plasma CXCL12 levels Eur Heart J 32 8 2011 963 971
15. J. Gupta, N. Mitra, P.A. Kanetsky, and et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC Clin J Am Soc Nephrol 7 12 2012 1938 1946
16. A.H. Anderson, W. Yang, C.Y. Hsu, and et al. Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study Am J Kidney Dis 60 2 2012 250 261
17. R.R. Townsend, A.H. Anderson, J. Chen, and et al. Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study Am J Nephrol 33 6 2011 477 484
18. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 7 1985 412 419
19. N.N. Mehta, G.J. Matthews, P. Krishnamoorthy, and et al. Higher plasma CXCL12 levels predict incident myocardial infarction and death in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort study Eur Heart J 35 31 2014 2115 2122
20. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2 2008 157 172 discussion 207-212
21. H. Ikejima, T. Imanishi, H. Tsujioka, and et al. Upregulation of fractalkine and its receptor, CX3CR1, is associated with coronary plaque rupture in patients with unstable angina pectoris Circ J 74 2 2010 337 345
22. P. Ancuta, R. Rao, A. Moses, and et al. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes J Exp Med 197 12 2003 1701 1707
23. F. Tacke, and G.J. Randolph Migratory fate and differentiation of blood monocyte subsets Immunobiology 211 6-8 2006 609 618
24. L. Landsman, L. Bar-On, A. Zernecke, and et al. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival Blood 113 4 2009 963 972
25. N. Saederup, L. Chan, S.A. Lira, and I.F. Charo Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis Circulation 117 13 2008 1642 1648
26. B. Richter, L. Koller, P.J. Hohensinner, and et al. Fractalkine is an independent predictor of mortality in patients with advanced heart failure Thromb Haemost 108 6 2012 1220 1227
27. D.L. Morris, K.E. Oatmen, T. Wang, J.L. DelProposto, and C.N. Lumeng CX3CR1 deficiency does not influence trafficking of adipose tissue macrophages in mice with diet-induced obesity Obesity 20 6 2012 1189 1199
28. Y.S. Lee, H. Morinaga, J.J. Kim, and et al. The fractalkine/CX3CR1 system regulates beta cell function and insulin secretion Cell 153 2 2013 413 425
29. J. Mestas, and C.C. Hughes Of mice and not men: differences between mouse and human immunology J Immunol 172 5 2004 2731 2738
30. S. Yoshimoto, K. Nakatani, M. Iwano, and et al. Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis Am J Kidney Dis 50 1 2007 47 58
31. K. Katsuyama, H. Fujinaka, K. Yamamoto, and et al. Expression of the chemokine fractalkine (FKN/CX3CL1) by podocytes in normal and proteinuric rat kidney glomerulus Nephron Exp Nephrol 113 2 2009 e45 e56
32. Y. Ito, H. Kawachi, Y. Morioka, and et al. Fractalkine expression and the recruitment of CX3CR1+ cells in the prolonged mesangial proliferative glomerulonephritis Kidney Int 61 6 2002 2044 2057
33. A.K. Yadav, A. Lal, and V. Jha Association of circulating fractalkine (CX3CL1) and CX3CR1(+)CD4(+) T cells with common carotid artery intima-media thickness in patients with chronic kidney disease J Atheroscler Thromb 18 11 2011 958 965